Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.

Thys-Jacobs S, McMahon D, Bilezikian JP.

Am J Obstet Gynecol. 2008 May;198(5):506.e1-8. doi: 10.1016/j.ajog.2007.11.005. Epub 2008 Jan 15.

PMID:
18199422
[PubMed - indexed for MEDLINE]
2.

Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.

Huo L, Straub RE, Roca C, Schmidt PJ, Shi K, Vakkalanka R, Weinberger DR, Rubinow DR.

Biol Psychiatry. 2007 Oct 15;62(8):925-33. Epub 2007 Jun 27.

PMID:
17599809
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder.

Thys-Jacobs S, McMahon D, Bilezikian JP.

J Clin Endocrinol Metab. 2007 Aug;92(8):2952-9. Epub 2007 May 8.

PMID:
17488795
[PubMed - indexed for MEDLINE]
4.

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.

Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A.

Obstet Gynecol. 2005 Sep;106(3):492-501.

PMID:
16135578
[PubMed - indexed for MEDLINE]
5.

No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder.

Hsiao CC, Liu CY, Hsiao MC.

Psychiatry Clin Neurosci. 2004 Dec;58(6):593-9.

PMID:
15601382
[PubMed - indexed for MEDLINE]
6.

Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome.

Cronje WH, Vashisht A, Studd JW.

Hum Reprod. 2004 Sep;19(9):2152-5. Epub 2004 Jun 30.

PMID:
15229203
[PubMed - indexed for MEDLINE]
Free Article
7.

Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome.

Blum I, Lerman M, Misrachi I, Nordenberg Y, Grosskopf I, Weizman A, Levy-Schiff R, Sulkes J, Vered Y.

Neuropsychobiology. 2004;50(1):10-5.

PMID:
15179014
[PubMed - indexed for MEDLINE]
8.

Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS).

Kelly MJ, Qiu J, Wagner EJ, Rønnekleiv OK.

J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):187-93. Review.

PMID:
12650715
[PubMed - indexed for MEDLINE]
9.

Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study.

Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA, Leondires MP, Greer PJ, Lopresti B, Loucks TL, Berga SL.

Biol Psychiatry. 2000 Oct 15;48(8):854-60.

PMID:
11063980
[PubMed - indexed for MEDLINE]
10.

Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system.

McEwen BS.

J Clin Endocrinol Metab. 1999 Jun;84(6):1790-7. Review. No abstract available.

PMID:
10372665
[PubMed - indexed for MEDLINE]
11.

Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?

Joffe H, Cohen LS.

Biol Psychiatry. 1998 Nov 1;44(9):798-811. Review.

PMID:
9807636
[PubMed - indexed for MEDLINE]
12.

Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.

Seippel L, Bäckström T.

J Clin Endocrinol Metab. 1998 Jun;83(6):1988-92.

PMID:
9626129
[PubMed - indexed for MEDLINE]
13.

Luteal phase ovarian steroids, stress arousal, premenses perceived stress, and premenstrual symptoms.

Woods NF, Lentz MJ, Mitchell ES, Shaver J, Heitkemper M.

Res Nurs Health. 1998 Apr;21(2):129-42.

PMID:
9535405
[PubMed - indexed for MEDLINE]
14.

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.

Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR.

N Engl J Med. 1998 Jan 22;338(4):209-16.

PMID:
9435325
[PubMed - indexed for MEDLINE]
Free Article
15.

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

Fink G, Sumner BE, Rosie R, Grace O, Quinn JP.

Cell Mol Neurobiol. 1996 Jun;16(3):325-44. Review.

PMID:
8818400
[PubMed - indexed for MEDLINE]
16.
17.

Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study.

Wiklund I, Karlberg J, Mattsson LA.

Am J Obstet Gynecol. 1993 Mar;168(3 Pt 1):824-30.

PMID:
8456888
[PubMed - indexed for MEDLINE]
18.

Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.

Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL.

Obstet Gynecol. 1994 Nov;84(5):779-86.

PMID:
7936512
[PubMed - indexed for MEDLINE]
19.

Neurochemical evidence that estrogen-induced suppression of kappa-opioid-receptor-mediated regulation of tuberoinfundibular dopaminergic neurons is prolactin-independent.

Wagner EJ, Manzanares J, Moore KE, Lookingland KJ.

Neuroendocrinology. 1994 Mar;59(3):197-201.

PMID:
7909142
[PubMed - indexed for MEDLINE]
20.

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D.

N Engl J Med. 1995 Jun 8;332(23):1529-34.

PMID:
7739706
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk